Rupert W Major1,2, Celia Brown3, David Shepherd1, Stephen Rogers1, Warren Pickering4, Graham L Warwick2, Shaun Barber5, Nuzhat B Ashra5, Tom Morris5, Nigel J Brunskill6,7. 1. Departments of Health Sciences and. 2. Department of Nephrology, University Hospitals of Leicester National Health Service Trust, Leicester, United Kingdom. 3. Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, United Kingdom; and. 4. Department of Nephrology, Northampton General Hospital, Northampton, Northants, United Kingdom. 5. Leicester Clinical Trials Unit, University of Leicester, Leicester, United Kingdom. 6. Department of Nephrology, University Hospitals of Leicester National Health Service Trust, Leicester, United Kingdom; njb18@le.ac.uk. 7. Infection Immunity and Inflammation and.
Abstract
BACKGROUND: Most patients with CKD are managed in the community. Whether nurse-led CKD management programs improve outcomes in patients with CKD in primary care is unclear. METHODS: To assess the effect of such a program on the rate of renal function decline in patients with CKD (stages 3-5) in primary care in the United Kingdom, we conducted a cluster randomized trial, the Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease study. A software program designed for the study created a data file of patients with CKD in participating practices. In 23 intervention practices (11,651 patients), a CKD nurse practitioner worked with nominated practice leads to interpret the data file and implement guideline-based patient-level CKD management interventions. The 23 control practices (11,706 patients) received a data file but otherwise, continued usual CKD care. The primary outcome was defined at the cluster (practice) level as the change from baseline of the mean eGFR of the patients with CKD at 6-month intervals up to 42 months. Secondary outcomes included numbers of patients coded for CKD, mean BP, numbers of patients achieving National Institute for Health and Care Excellence BP targets for CKD, and proteinuria measurement. RESULTS: After 42 months, eGFR did not differ significantly between control and intervention groups. CKD- and proteinuria-related coding improved significantly along with the number of patients achieving BP targets in the intervention group versus usual care. CONCLUSIONS: CKD management programs in primary care may not slow progression of CKD, but they may significantly improve processes of care and potentially decrease the cardiovascular disease burden in CKD and related costs.
RCT Entities:
BACKGROUND: Most patients with CKD are managed in the community. Whether nurse-led CKD management programs improve outcomes in patients with CKD in primary care is unclear. METHODS: To assess the effect of such a program on the rate of renal function decline in patients with CKD (stages 3-5) in primary care in the United Kingdom, we conducted a cluster randomized trial, the Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease study. A software program designed for the study created a data file of patients with CKD in participating practices. In 23 intervention practices (11,651 patients), a CKD nurse practitioner worked with nominated practice leads to interpret the data file and implement guideline-based patient-level CKD management interventions. The 23 control practices (11,706 patients) received a data file but otherwise, continued usual CKD care. The primary outcome was defined at the cluster (practice) level as the change from baseline of the mean eGFR of the patients with CKD at 6-month intervals up to 42 months. Secondary outcomes included numbers of patients coded for CKD, mean BP, numbers of patients achieving National Institute for Health and Care Excellence BP targets for CKD, and proteinuria measurement. RESULTS: After 42 months, eGFR did not differ significantly between control and intervention groups. CKD- and proteinuria-related coding improved significantly along with the number of patients achieving BP targets in the intervention group versus usual care. CONCLUSIONS: CKD management programs in primary care may not slow progression of CKD, but they may significantly improve processes of care and potentially decrease the cardiovascular disease burden in CKD and related costs.
Authors: Ann M O'Hare; Andy I Choi; Daniel Bertenthal; Peter Bacchetti; Amit X Garg; James S Kaufman; Louise C Walter; Kala M Mehta; Michael A Steinman; Michael Allon; William M McClellan; C Seth Landefeld Journal: J Am Soc Nephrol Date: 2007-09-12 Impact factor: 10.121
Authors: Nick Richards; Kevin Harris; Malcolm Whitfield; Donal O'Donoghue; Robert Lewis; Martin Mansell; Stephen Thomas; John Townend; Mick Eames; Daniele Marcelli Journal: Nephrol Dial Transplant Date: 2007-12-09 Impact factor: 5.992
Authors: P E Stevens; D J O'Donoghue; S de Lusignan; J Van Vlymen; B Klebe; R Middleton; N Hague; J New; C K T Farmer Journal: Kidney Int Date: 2007-04-18 Impact factor: 10.612
Authors: Carmen A Peralta; Jennifer Livaudais-Toman; Marilyn Stebbins; Lowell Lo; Andrew Robinson; Sarita Pathak; Rebecca Scherzer; Leah S Karliner Journal: Am J Kidney Dis Date: 2020-07-22 Impact factor: 8.860
Authors: Carola van Dipten; Davy Gerda Hermina Antoin van Dam; Wilhelmus Joannes Carolus de Grauw; Marcus Antonius Gerard Jan Ten Dam; Marcus Matheus Hendrik Hermans; Willem Jan Jozef Assendelft; Nynke Dorothea Scherpbier-de Haan; Jacobus Franciscus Maria Wetzels Journal: BMC Nephrol Date: 2021-05-19 Impact factor: 2.388
Authors: Navdeep Tangri; Amit X Garg; Thomas W Ferguson; Stephanie Dixon; Claudio Rigatto; Selina Allu; Elaine Chau; Paul Komenda; David Naimark; Gihad E Nesrallah; Steven D Soroka; Monica Beaulieu; Ahsan Alam; S Joseph Kim; Manish M Sood; Braden Manns Journal: J Am Soc Nephrol Date: 2021-04-15 Impact factor: 14.978
Authors: Hilda O Hounkpatin; Geraldine M Leydon; Kristin Veighey; Kirsten Armstrong; Miriam Santer; Maarten W Taal; Pete Annells; Carl May; Paul J Roderick; Simon Ds Fraser Journal: BMJ Open Date: 2020-12-12 Impact factor: 2.692
Authors: Simon Ds Fraser; Jenny Barker; Paul J Roderick; Ho Ming Yuen; Adam Shardlow; James E Morris; Natasha J McIntyre; Richard J Fluck; Chris W McIntyre; Maarten W Taal Journal: BMJ Open Date: 2020-08-06 Impact factor: 2.692
Authors: Alessandro Gasparini; Keith R Abrams; Jessica K Barrett; Rupert W Major; Michael J Sweeting; Nigel J Brunskill; Michael J Crowther Journal: Stat Neerl Date: 2019-09-05 Impact factor: 1.190